Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, ...

The "Syringe Pumps Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering.

Fresenius and Charles River Laboratories are among 18 academic, research, industry and clinical partners that have formed a new European Union-supported consortium to develop an automated, ...

Fresenius Kabi's tocilizumab biosimilar Tyenne ® is the first and only tocilizumab biosimilar to be launched in Canada and is now commercially available for both subcutaneous and intravenous ...

Fresenius SE FRE0.43%increase; green up pointing triangle said it raised around 1.1 billion euros ($1.15 billion) after selling part of its Fresenius Medical Care FME-0.22%decrease; red down pointing ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The "Elastomeric Infusion Pumps Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region ...

TORONTO, Jan. 8, 2025 /CNW/ - Fresenius Kabi Canada proudly announces the recent Health Canada Notice of Compliance (NOC) for Otulfi TM, an ustekinumab biosimilar indicated for Crohn's disease, ...

Global infusion pump market was valued at US$ 8.87 Bn in 2022 and is forecast to reach a value of US$ 16.91 Bn by 2030 at a CAGR of 8.4% between 2023 and 2030 BURLINGAME, CA, UNITED STATES, December ...

Fresenius Kabi warned healthcare providers in a Dec. 5 letter to stop using certain Ivenix large-volume pumps because of the risk that pneumatic valves installed in some devices could issue a pump ...

Fresenius Kabi is asking hospitals to remove certain pumps because of the risk of an alarm that could interrupt treatment. The FDA rolled out its early alert program last month, with the goal of ...

The early alert on Fresenius’ device is part of a new pilot by the FDA to improve the timeliness around public communications over potentially high-risk device recalls. Image credit: Tada Images via ...

The Ivenix infusion system. [Image courtesy of Fresenius Kabi] The FDA said Fresenius Kabi told customers to remove its Ivenix large-volume infusion pumps from use for repair. This warning from the ...